408 related articles for article (PubMed ID: 35444234)
1. p53 at the crossroad of DNA replication and ribosome biogenesis stress pathways.
Lindström MS; Bartek J; Maya-Mendoza A
Cell Death Differ; 2022 May; 29(5):972-982. PubMed ID: 35444234
[TBL] [Abstract][Full Text] [Related]
2. The roles of RRP15 in nucleolar formation, ribosome biogenesis and checkpoint control in human cells.
Dong Z; Zhu C; Zhan Q; Jiang W
Oncotarget; 2017 Feb; 8(8):13240-13252. PubMed ID: 28099941
[TBL] [Abstract][Full Text] [Related]
3. Activation of the tumor suppressor p53 upon impairment of ribosome biogenesis.
Bursac S; Brdovcak MC; Donati G; Volarevic S
Biochim Biophys Acta; 2014 Jun; 1842(6):817-30. PubMed ID: 24514102
[TBL] [Abstract][Full Text] [Related]
4. Perturbation of RNA Polymerase I transcription machinery by ablation of HEATR1 triggers the RPL5/RPL11-MDM2-p53 ribosome biogenesis stress checkpoint pathway in human cells.
Turi Z; Senkyrikova M; Mistrik M; Bartek J; Moudry P
Cell Cycle; 2018; 17(1):92-101. PubMed ID: 29143558
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic MYC Induces the Impaired Ribosome Biogenesis Checkpoint and Stabilizes p53 Independent of Increased Ribosome Content.
Morcelle C; Menoyo S; Morón-Duran FD; Tauler A; Kozma SC; Thomas G; Gentilella A
Cancer Res; 2019 Sep; 79(17):4348-4359. PubMed ID: 31292158
[TBL] [Abstract][Full Text] [Related]
6. Dysregulated Ribosome Biogenesis Reveals Therapeutic Liabilities in Cancer.
Bursać S; Prodan Y; Pullen N; Bartek J; Volarević S
Trends Cancer; 2021 Jan; 7(1):57-76. PubMed ID: 32948502
[TBL] [Abstract][Full Text] [Related]
7. Acrolein preferentially damages nucleolus eliciting ribosomal stress and apoptosis in human cancer cells.
Wang HT; Chen TY; Weng CW; Yang CH; Tang MS
Oncotarget; 2016 Dec; 7(49):80450-80464. PubMed ID: 27741518
[TBL] [Abstract][Full Text] [Related]
8. A new PICTure of nucleolar stress.
Suzuki A; Kogo R; Kawahara K; Sasaki M; Nishio M; Maehama T; Sasaki T; Mimori K; Mori M
Cancer Sci; 2012 Apr; 103(4):632-7. PubMed ID: 22320853
[TBL] [Abstract][Full Text] [Related]
9. The Effects of Deregulated Ribosomal Biogenesis in Cancer.
Lu Y; Wang S; Jiao Y
Biomolecules; 2023 Oct; 13(11):. PubMed ID: 38002277
[TBL] [Abstract][Full Text] [Related]
10. GRWD1, a new player among oncogenesis-related ribosomal/nucleolar proteins.
Takafuji T; Kayama K; Sugimoto N; Fujita M
Cell Cycle; 2017 Aug; 16(15):1397-1403. PubMed ID: 28722511
[TBL] [Abstract][Full Text] [Related]
11. Cancer-associated mutations in the ribosomal protein L5 gene dysregulate the HDM2/p53-mediated ribosome biogenesis checkpoint.
Oršolić I; Bursać S; Jurada D; Drmić Hofman I; Dembić Z; Bartek J; Mihalek I; Volarević S
Oncogene; 2020 Apr; 39(17):3443-3457. PubMed ID: 32108164
[TBL] [Abstract][Full Text] [Related]
12. RNA-interference screen for p53 regulators unveils a role of WDR75 in ribosome biogenesis.
Moudry P; Chroma K; Bursac S; Volarevic S; Bartek J
Cell Death Differ; 2022 Mar; 29(3):687-696. PubMed ID: 34611297
[TBL] [Abstract][Full Text] [Related]
13. Perturbation of ribosome biogenesis drives cells into senescence through 5S RNP-mediated p53 activation.
Nishimura K; Kumazawa T; Kuroda T; Katagiri N; Tsuchiya M; Goto N; Furumai R; Murayama A; Yanagisawa J; Kimura K
Cell Rep; 2015 Mar; 10(8):1310-23. PubMed ID: 25732822
[TBL] [Abstract][Full Text] [Related]
14. mTOR inhibitors blunt the p53 response to nucleolar stress by regulating RPL11 and MDM2 levels.
Goudarzi KM; Nistér M; Lindström MS
Cancer Biol Ther; 2014; 15(11):1499-514. PubMed ID: 25482947
[TBL] [Abstract][Full Text] [Related]
15. The Evolution of the Ribosomal Protein-MDM2-p53 Pathway.
Deisenroth C; Franklin DA; Zhang Y
Cold Spring Harb Perspect Med; 2016 Dec; 6(12):. PubMed ID: 27908926
[TBL] [Abstract][Full Text] [Related]
16. Nuclear stabilization of p53 requires a functional nucleolar surveillance pathway.
Hannan KM; Soo P; Wong MS; Lee JK; Hein N; Poh P; Wysoke KD; Williams TD; Montellese C; Smith LK; Al-Obaidi SJ; Núñez-Villacís L; Pavy M; He JS; Parsons KM; Loring KE; Morrison T; Diesch J; Burgio G; Ferreira R; Feng ZP; Gould CM; Madhamshettiwar PB; Flygare J; Gonda TJ; Simpson KJ; Kutay U; Pearson RB; Engel C; Watkins NJ; Hannan RD; George AJ
Cell Rep; 2022 Nov; 41(5):111571. PubMed ID: 36323262
[TBL] [Abstract][Full Text] [Related]
17. Growth control and ribosomopathies.
Teng T; Thomas G; Mercer CA
Curr Opin Genet Dev; 2013 Feb; 23(1):63-71. PubMed ID: 23490481
[TBL] [Abstract][Full Text] [Related]
18. Impaired ribosome biogenesis checkpoint activation induces p53-dependent MCL-1 degradation and MYC-driven lymphoma death.
Domostegui A; Peddigari S; Mercer CA; Iannizzotto F; Rodriguez ML; Garcia-Cajide M; Amador V; Diepstraten ST; Kelly GL; Salazar R; Kozma SC; Kusnadi EP; Kang J; Gentilella A; Pearson RB; Thomas G; Pelletier J
Blood; 2021 Jun; 137(24):3351-3364. PubMed ID: 33512431
[TBL] [Abstract][Full Text] [Related]
19. Ribosomal proteins as unrevealed caretakers for cellular stress and genomic instability.
Kim TH; Leslie P; Zhang Y
Oncotarget; 2014 Feb; 5(4):860-71. PubMed ID: 24658219
[TBL] [Abstract][Full Text] [Related]
20. Ribosome biogenesis surveillance: probing the ribosomal protein-Mdm2-p53 pathway.
Deisenroth C; Zhang Y
Oncogene; 2010 Jul; 29(30):4253-60. PubMed ID: 20498634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
